Search research articles
Contact Us
Filters
Showing results (191-200 of 266) with videos related to
Page
of 27
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 13, 2010
Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease
Ray L Watts, Kelly E Lyons, Rajesh Pahwa, et al.
Neurology
|
May 12, 2017
Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease
Fabrizio Stocchi, Olivier Rascol, Robert A Hauser, et al.
Movement Disorders Clinical Practice
|
April 8, 2020
Practical Evaluation and Management of Insomnia in Parkinson's Disease: A Review
Douglas M Wallace, William K Wohlgemuth, Lynn Marie Trotti, et al.
The American Journal of Psychiatry
|
March 22, 2017
KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia
Robert A Hauser, Stewart A Factor, Stephen R Marder, et al.
JAMA Neurology
|
December 13, 2016
Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial
Anthony H V Schapira, Susan H Fox, Robert A Hauser, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 15, 2011
Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease
Robert A Hauser, Aaron L Ellenbogen, Leo Verhagen Metman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 21, 2023
Scales for Antipsychotic-Associated Movement Disorders: Systematic Review, Critique, and Recommendations
Davide Martino, Vikram Karnik, Roongroj Bhidayasiri, et al.
Journal of Parkinson'S Disease
|
September 6, 2021
Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson's Disease: A Pooled Analysis of 8 Phase 2b/3 Trials
Robert A Hauser, Nobutaka Hattori, Hubert Fernandez, et al.
Archives of Neurology
|
August 16, 2006
Deep brain stimulation of the internal segment of the globus pallidus in delayed runaway dyskinesia
John Graff-Radford, Kelly D Foote, Ramon L Rodriguez, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 24, 2017
Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3)
Wolfgang Oertel, Karla Eggert, Rajesh Pahwa, et al.
Page
of 27
Search research articles
Search
Showing results (191-200 of 266) with videos related to
Sort By:
Page
of 27
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 13, 2010
Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease
Ray L Watts, Kelly E Lyons, Rajesh Pahwa, et al.
Neurology
|
May 12, 2017
Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease
Fabrizio Stocchi, Olivier Rascol, Robert A Hauser, et al.
Movement Disorders Clinical Practice
|
April 8, 2020
Practical Evaluation and Management of Insomnia in Parkinson's Disease: A Review
Douglas M Wallace, William K Wohlgemuth, Lynn Marie Trotti, et al.
The American Journal of Psychiatry
|
March 22, 2017
KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia
Robert A Hauser, Stewart A Factor, Stephen R Marder, et al.
JAMA Neurology
|
December 13, 2016
Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial
Anthony H V Schapira, Susan H Fox, Robert A Hauser, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 15, 2011
Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease
Robert A Hauser, Aaron L Ellenbogen, Leo Verhagen Metman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 21, 2023
Scales for Antipsychotic-Associated Movement Disorders: Systematic Review, Critique, and Recommendations
Davide Martino, Vikram Karnik, Roongroj Bhidayasiri, et al.
Journal of Parkinson'S Disease
|
September 6, 2021
Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson's Disease: A Pooled Analysis of 8 Phase 2b/3 Trials
Robert A Hauser, Nobutaka Hattori, Hubert Fernandez, et al.
Archives of Neurology
|
August 16, 2006
Deep brain stimulation of the internal segment of the globus pallidus in delayed runaway dyskinesia
John Graff-Radford, Kelly D Foote, Ramon L Rodriguez, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 24, 2017
Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3)
Wolfgang Oertel, Karla Eggert, Rajesh Pahwa, et al.
Page
of 27